Literature DB >> 1720571

Identification of a competitive HGF antagonist encoded by an alternative transcript.

A M Chan1, J S Rubin, D P Bottaro, D W Hirschfield, M Chedid, S A Aaronson.   

Abstract

We identified a naturally occurring hepatocyte growth factor (HGF) variant, whose predicted sequence extends only through the second kringle domain of this plasminogen-related molecule. This smaller molecule, derived from an alternative HGF transcript, lacked mitogenic activity but specifically inhibited HGF-induced mitogenesis. Cross-linking studies demonstrated that the truncated molecule competes with HGF for binding to the HGF receptor, which has been identified as the c-met protooncogene product. Thus, the same gene encodes both a growth factor and its direct antagonist.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1720571     DOI: 10.1126/science.1720571

Source DB:  PubMed          Journal:  Science        ISSN: 0036-8075            Impact factor:   47.728


  49 in total

1.  Regulatory proteins and cis-acting elements involved in the transcriptional control of Rhizobium etli reiterated nifH genes.

Authors:  B Valderrama; A Dávalos; L Girard; E Morett; J Mora
Journal:  J Bacteriol       Date:  1996-06       Impact factor: 3.490

2.  Overexpression of NK2 inhibits liver regeneration after partial hepatectomy in mice.

Authors:  Toshiyuki Otsuka; Norio Horiguchi; Daisuke Kanda; Takashi Kosone; Yuichi Yamazaki; Kazuhisa Yuasa; Naondo Sohara; Satoru Kakizaki; Ken Sato; Hitoshi Takagi; Glenn Merlino; Masatomo Mori
Journal:  World J Gastroenterol       Date:  2005-12-21       Impact factor: 5.742

3.  Mast cell and neutrophil peptidases attack an inactivation segment in hepatocyte growth factor to generate NK4-like antagonists.

Authors:  Wilfred W Raymond; Anthony C Cruz; George H Caughey
Journal:  J Biol Chem       Date:  2005-11-22       Impact factor: 5.157

4.  Structural basis for agonism and antagonism of hepatocyte growth factor.

Authors:  W David Tolbert; Jennifer Daugherty-Holtrop; Ermanno Gherardi; George Vande Woude; H Eric Xu
Journal:  Proc Natl Acad Sci U S A       Date:  2010-07-12       Impact factor: 11.205

5.  Functional and biophysical characterization of recombinant human hepatocyte growth factor isoforms produced in Escherichia coli.

Authors:  S J Stahl; P T Wingfield; J D Kaufman; L K Pannell; V Cioce; H Sakata; W G Taylor; J S Rubin; D P Bottaro
Journal:  Biochem J       Date:  1997-09-15       Impact factor: 3.857

Review 6.  Molecular background of the regional lymph node metastasis of gastric cancer.

Authors:  Tong Zhu; Xueqian Hu; Pinkang Wei; Guangzhi Shan
Journal:  Oncol Lett       Date:  2018-01-16       Impact factor: 2.967

7.  Cell-specific expression of hepatocyte growth factor in liver. Upregulation in sinusoidal endothelial cells after carbon tetrachloride.

Authors:  J J Maher
Journal:  J Clin Invest       Date:  1993-05       Impact factor: 14.808

8.  High concentrations of HGF inhibit skeletal muscle satellite cell proliferation in vitro by inducing expression of myostatin: a possible mechanism for reestablishing satellite cell quiescence in vivo.

Authors:  Michiko Yamada; Ryuichi Tatsumi; Keitaro Yamanouchi; Tohru Hosoyama; Sei-ichi Shiratsuchi; Akiko Sato; Wataru Mizunoya; Yoshihide Ikeuchi; Mitsuhiro Furuse; Ronald E Allen
Journal:  Am J Physiol Cell Physiol       Date:  2009-12-09       Impact factor: 4.249

9.  Hepatocyte growth factor (HGF/SF) is expressed in human epithelial cells during embryonic development; studies by in situ hybridisation and northern blot analysis.

Authors:  Y Wang; C Selden; S Farnaud; D Calnan; H J Hodgson
Journal:  J Anat       Date:  1994-12       Impact factor: 2.610

10.  Keratinocyte growth factor and hepatocyte growth factor/scatter factor are heparin-binding growth factors for alveolar type II cells in fibroblast-conditioned medium.

Authors:  R J Panos; J S Rubin; K G Csaky; S A Aaronson; R J Mason
Journal:  J Clin Invest       Date:  1993-08       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.